31 December 2019 3 5K Report

WHO has established a reference preparation for hCG (currently the fourth International Standard, with an assigned content of 650 IU/ampoule) and a reference preparation for hCG-beta (currently the first WHO Reference Reagent for immunoassay of hCG beta subunit, with an assigned content of 0.88nmol/ampoule)

650 IU/ampoule

0.88nmol/ampoule

The former preparation was assigned a value based on bioassay, whereas the latter preparation had been extensively characterized by physicochemical and immunological methods and calibrated in nanomol by amino acid analysis.

If I understood correctly based on the 0.88nmol they have determined the 650 IU

What bioassay have they done to derive 650 IU/ampoule? an example will be good.

250 micrograms (μg) of r-hCG represent 6.8 nmols/liter and should equate to approximately 2,325 IU of bioactivity.

How is the bioactivity experiment designed or steps of how its done?

Say I have 100 μg/ml of r-hCG and I need to express it in IU/ml, steps for conversion or experiment design for clinical evaluation?

More Xin Pin's questions See All
Similar questions and discussions